XML 36 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment information
 3 Months Ended
Apr. 02, 2017
Segment Reporting [Abstract]  
Segment information
Note 14 — Segment information
The following tables present the Company’s segment results for the three months ended April 2, 2017 and March 27, 2016:
 
Three Months Ended
 
April 2, 2017
 
March 27, 2016
 
(Dollars in thousands)
Revenue
 
 
 
Vascular North America
$
93,849

 
$
81,588

Anesthesia North America
48,207

 
45,957

Surgical North America
45,944

 
38,941

EMEA
130,733

 
122,095

Asia
48,953

 
49,156

OEM
43,346

 
33,977

All other
76,849

 
53,179

Consolidated net revenues
$
487,881

 
$
424,893

 
Three Months Ended
 
April 2, 2017
 
March 27, 2016
 
(Dollars in thousands)
Operating profit
 
 
 
Vascular North America
$
24,816

 
$
19,656

Anesthesia North America
13,527

 
12,177

Surgical North America
16,380

 
13,256

EMEA
22,240

 
21,043

Asia
10,798

 
13,008

OEM
9,121

 
5,189

All other
(6,301
)
 
5,743

Total segment operating profit (1)
90,581

 
90,072

Unallocated expenses (2)
(29,762
)
 
(22,575
)
Income from continuing operations before interest, loss on extinguishment of debt and taxes
$
60,819

 
$
67,497

(1)
Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Corporate expenses are allocated among the segments in proportion to the respective amounts of one of several items (such as net revenues, numbers of employees, and amount of time spent), depending on the category of expense involved.
(2)
Unallocated expenses primarily include manufacturing variances, with the exception of fixed manufacturing cost absorption variances, restructuring charges and gain on sale of assets.